NCT04754945 2026-02-18Isatuximab as Upfront Therapy for the Treatment of High Risk AL AmyloidosisEmory UniversityPhase 1 Active not recruiting11 enrolled
NCT01728259 2023-05-09First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDBarbara Ann Karmanos Cancer InstitutePhase 1 Terminated18 enrolled